Our understanding of the molecular mechanisms of bacterial pathogenesis has been improved especially by the discovery of host cell contact-dependent secretion systems such as the type-III secretion system (T3SS) found in numerous pathogens. Although the identification of pathogen effectors translocated into host cells through T3SS is essential to the understanding of pathogenesis, their general sequence uniqueness confound attempts to identify such proteins by sequence homology. Here we report the development of a functional high-throughput screening system for pathogen effectors in yeast that consists of a Gateway TM -compatible Tet-Off inducible expression vector and a yeast strain expressing a reporter, facilitating identification of the effectors affecting host vesicular trafficking pathways. We evaluated this system and optimized the screening condition using several known pathogen effectors. We found this system useful in functional characterization of pathogen effector and it can be adapted to functional high-throughput screening as well.
Our understanding of the molecular mechanisms of bacterial pathogenesis has been improved especially by the discovery of host cell contact-dependent secretion systems such as the type-III secretion system (T3SS) found in numerous pathogens. Although the identification of pathogen effectors translocated into host cells through T3SS is essential to the understanding of pathogenesis, their general sequence uniqueness confound attempts to identify such proteins by sequence homology. Here we report the development of a functional high-throughput screening system for pathogen effectors in yeast that consists of a Gateway TM -compatible Tet-Off inducible expression vector and a yeast strain expressing a reporter, facilitating identification of the effectors affecting host vesicular trafficking pathways. We evaluated this system and optimized the screening condition using several known pathogen effectors. We found this system useful in functional characterization of pathogen effector and it can be adapted to functional high-throughput screening as well.
Key words: inducible promoter; Type III secretion system; Saccharomyces cerevisiae; pathogenesis Numerous bacterial pathogens of plants and animals utilize specialized secretion apparatuses such as the type III, type IV, type VI, and type VII secretion systems to inject effector proteins directly into the host cell cytoplasm. [1] [2] [3] [4] Consequently, translocated effector proteins manipulate host cellular processes including cytoskeletal reorganization, vesicular trafficking, autophagy, signal transduction, and DNA replication to promote infection and ultimately cause disease. 5) Although the identification and characterization of these effector proteins is essential in order to understand pathogenesis, it has been very difficult due to a lack of detectable signal sequences and functional redundancy. Effector proteins of pathogens of humans have been observed to confer toxic phenotypes when expressed in the yeast Sacchromyces cerevisiae.
6,7)
Numerous effectors from various bacterial pathogens such as Yersinia, 8, 9) Salmonella, 10, 11) Pseudomonas, 12, 13) Vibrio, 14) Legionella, 15, 16) Campylobacter, 17) and Chlamydia 18, 19) have been expressed in yeast and have been found to interfere with cellular functions related to their proposed targets within the host cell, such as Rho-type small GTPase, mitogen-activated protein kinase (MAPK) cascades, vesicle trafficking, DNA, the actin cytoskeleton, and microtubules. These reports indicate that the yeast system is powerful tool in the identification and characterization of pathogen effectors. Furthermore, recent evidence indicates that the generation of yeast growth phenotypes by ectopic expression of bacterial proteins shows a unique property of effector proteins, since the expression of non-effector proteins rarely causes growth defects. 20) For example, Slagowski et al. 20) reported that the expression of half of the 19 Shigella effector proteins tested but of almost none of the 20 Shigella non-effector proteins or the approximately 1,000 Francisella tularensis proteins are predicted to be common housekeeping proteins significantly inhibited yeast growth. Therefore, the growth phenotypes caused by the expression of bacterial effector proteins are probably due to disruption of specific host cell targets. These growth defects are genetically tractable phenotypes, and they provide a variety of means to investigate the action of these molecules towards host cell factors.
Here we report the development of a novel functional high-throughput screening system for pathogen effectors in yeast. First we constructed the GatewayÔ-compatible Tet-Off inducible expression vector to enable us to analyze the pathogen effectors conferring the growth inhibitory phenotype on yeast. This novel expression vector allows comprehensive gene cloning by the GatewayÔ technology and tightly controlled gene expression by means of the doxycyline concentration in the culture medium. Secondly, we generated a yeast strain expressing the reporter protein to monitor endosomal functions, which makes possible identification of the pathogen effectors affecting the host vesicular trafficking pathways. We evaluated this system and optimized the screening conditions using pathogen effectors previously found to confer a growth inhibitory phenotype on yeast. We found that the system developed was useful in the identification and characterization of pathogen effectors in yeast.
Materials and Methods
Strains and media. The enzymes used in recombinant DNA techniques were used as recommended by the manufacturer. Standard recombinant DNA techniques and yeast genetic methods were performed; the growth media used have been described elsewhere. 21, 22) The Sacchromyces cerevisiae strains used are described in Table 1 . Escherichia coli DB3.1 (Invitrogen, Carlsbad, CA) was used the construction and amplification of the GatewayÔ vectors, and E. coli DH5 was the bacterial host for all the other plasmids constructed.
Construction of GatewayÔ-compatible Tet-Off inducible expression vector for regulatable gene expression. The yeast GatewayÔ-compatible Tet-Off inducible expression vector was constructed as follows: The fragments of a modified Tet response element (TRE mod ) amplified from pTRE-tight vector (Clontech Laboratories, Palo Alto, CA) by polymerase chain reaction (PCR) using KOD plus DNA polymerase (Toyobo, Osaka, Japan) and the minimal yeast cytochrome C gene promoter (CYC1 TATA) amplified from yeast genomic DNA by PCR were ligated using T4 DNA ligase, and then the ligation product was used as a template to amplify the TRE mod -CYC1 TATA fusion gene (P Tet-OFF ) fragment. The P Tet-OFF fragment was cloned into the BglII/XhoI sites of pEGFPN1 (Clontech Laboratories) to generate pEGFPN1-P Tet-OFF plasmid. The fragment containing the Tetcontrolled transactivator protein, tTA2
S , from pTet-Off-Advanced (Clontech Laboratories) was cloned into the downstream of the yeast ADH1 promoter to generate the pUC13-P ADH1 -tTA2 s plasmid. The fragment containing P ADH1 -tTA2 S was cloned into the SacI/XhoI sites of the pEGFP-P Tet-OFF plasmid to generate the pEGFP-tTA2
S -P ADH1 -P Tet-OFF plasmid. The fragment containing the yeast ADH1 terminator (T ADH1 ) was cloned into the XhoI site of the pEGFP-tTA2
S -P ADH1 -P Tet-OFF plasmid to generate the pEGFP-tTA2
S -P ADH1 -T ADH1 -P Tet-OFF plasmid. A fragment of the yeast GAL1 promoter (P GAL1 ) from pYES2-DEST52 vector (Invitrogen) was cloned into the pRS416 and pRS426 yeast cloning vectors to generate pRS416-P GAL1 and pRS426-P GAL1 respectively. The fragment containing LAPG (localization and affinity purification-tag of GFP), which consists of a hexahistidine-tag and a GFP-tag with the tobacco etch virus (TEV) protease cleavage site between them, 23) was cloned into the BamHI/NotI sites of pRS416-P GAL1 and pRS426-P GAL1 to generate pRS416-P GAL1 -LAPG and pRS426-P GAL1 -LAPG respectively. The BglII/BglII-fragment containing the GatewayÔ cassette amplified from pYES2-DEST52 by PCR was cloned into the BamHI sites of pRS416-P GAL1 -LAPG and pRS426-P GAL1 -LAPG to generate pMT677 and pMT751 respectively. The GAL1 promoter regions of pMT677 and pMT751 were replaced with the BglII/SacI-fragment containing tTA2
S -P ADH1 -T ADH1 -P Tet-OFF from the pEGFP-tTA2
S -P ADH1 -T ADH1 -P Tet-OFF plasmid to generate pMT735 and pMT830 respectively. The plasmids constructed in this study are listed in Table 2 , and a map of pMT830 is shown in Fig. 1A .
Construction of pathogen effector-expression plasmids. Yersinia enterocolitica effectors, YopE, YopM, and YpkA, and Salmonella typhimurium effectors, SopE2, SptP, and SigD/SopB, were amplified by PCR using plasmids pCFL110, pCFL140, and pCFL150 (gifts of Dr. Samuel Miller), 9) and pKG-SopE2, pKG-SptP, and YCpLG-SigD (gifts of Dr. Maria Molina) 10, 11) respectively. Oligonucleotides were designed so that their 3 0 ends were specific to the various pathogen effector genes and their 5 0 ends partially overlapped the sequences of the attB-adaptor primers, as described in the GatewayÔ technology instruction manual (Invitrogen) ( Table 3 ). The 1st PCR products were further amplified using attB-adaptor primers to obtain the attB-flanked PCR product. PCR was performed using KOD plus DNA polymerase (Toyobo). The attB-flanked PCR products were purified from agarose gel and cloned into pDONR221 vector by BP reaction to generate the entry clones for the pathogen effectors. Subsequently the inserts of the entry clones were subcloned into pMT751 or pMT830 by LR reaction to generate yeast-inducible expression plasmids for the pathogen effectors.
Chromosomal integration of the PRC1-SUC2 gene. The SUC2 gene, containing the 565 bp-sequence of the 5 0 -upstream region of the SUC2 gene and the coding sequence for S. cerevisiae invertase, Inv amino acids 1 to 386, was amplified from yeast genomic DNA by PCR with KOD plus DNA polymerase (Toyobo), and cloned into the pUC13 plasmid to generate pUC13-SUC2. The PRC1 gene, containing the 611 bp-sequence of the 5 0 -upstream region of the PRC1 gene and the coding sequence for S. cerevisiae carboxypeptidase Y, CPY amino acids 1 to 434, was amplified from yeast genomic DNA by PCR and cloned into the linearized pUC13-SUC2 plasmid to generate the pUC13-5 0 -SUC2-PRC1-SUC2 plasmid, which resulted in in-frame gene fusion between the coding sequence for CPY amino acids 1 to 434 and Inv amino acids 150 to 386. The LEU2 gene was inserted into the junction between 5
0 -SUC2 and PRC1 to generate pUC13-5 0 -SUC2-LEU2-PRC1-SUC2. The 5 0 -SUC2-LEU2-PRC1-SUC2 fragment was 
Tet-Off attR1, Cm r , ccdB, attR2
a Plasmids used as vectors: pRS416 (centromeric, URA3) and pRS426 (2", URA3) b LAPG stands for Localization and Affinity Purification tag of GFP, which consists of a hexahistidine-tag and GFP-tag with the tobacco etch virus (TEV) protease cleavage site between them. c LAPR stands for Localization and Affinity Purification tag of RFP, which consists of a hexahistidine-tag and mCherry-tag with the tobacco etch virus (TEV) protease cleavage site between them.
amplified by PCR. The amplified fragment was transformed into a wildtype haploid strain, BY4742 by the standard lithium acetate method. 24) Leuþ transformants were analyzed by PCR to verify correct integration of the PRC1-SUC2 fusion construct. MTY 472 (suc2::LEU2-PRC1-SUC2) was crossed with MTY446 (suc2Á::His3MX6) to generate a diploid strain, MTY483.
Invertase overlay assay. Invertase overlay assay was performed as described previously. 25) Ten-fold serial diluted yeast cultures were spotted on SC-Ura/fructose with and without 20 mg/ml of doxycycline and grown for 2 d at 30
C. The plates were overlaid with 0.75% agarose solution containing 125 mM sucrose, 100 mM sodium acetate buffer (pH 5.5), 0.5 mM N-ethylmaleimide (NEM), 10 mg/ml of horseradish peroxidase, 8 units/ml of glucose oxidase, and 2 mM O-dianisidine. After 5-15 min, photographs were taken with a Nikon D70 digital single-lens reflex camera. Image contrast was adjusted using Adobe Photoshop CS2 software (Adobe Systems, San Jose, CA).
Protein extraction and immunoblot analysis. Yeast cells expressing GFP alone or GFP tagged Vps4
E233Q were collected and resuspended in 1 ml of PBS. After the addition of trichloroacetic acid (TCA) to a final concentration of 10%, the cells were incubated on ice for 15 min and precipitated by centrifugation. TCA-treated yeast cells were washed with 1 ml of ice-cold acetone twice and dried. Total proteins were extracted from the dried cells by beating them with glass beads (5 min Â 2 pulses at a 5-min interval at 65 C) in Urea-SDS cracking buffer (6 M urea, 1% SDS, 50 mM Tris-HCl, pH 7.5). The total protein concentration of the cell extracts was determined using a BCA protein assay kit (Pierce, Rockford, IL). Ten-mg aliquots of total protein were subjected to immunoblot analysis, which was done using affinitypurified rabbit anti-GFP antiserum (our laboratory stock) and horseradish peroxidase-conjugated anti-rabbit IgG serum (Cell Signaling Technology, Beverly, MA). Signals were detected using Pierce SuperSignal West Pico chemiluminescent detection reagent (Pierce, Rockford, IL).
Fluorescence microscopy. Yeast cells carrying GFP-tagged Vps4
E233Q were grown overnight in 3 ml of SC-Ura/glucose containing 20 mg/ml of doxycycline at 30 C. The cultures were then back-diluted to OD 600 of 0.2 in 10 ml of SC-Ura/glucose with 20 mg/ml of doxycycline and grown to OD 600 of about 1.5 at 30
C. The cultures were washed with SC-Ura/glucose without docycycline twice, resuspended to OD 600 of 1.0 in 5 ml of SC-Ura/glucose without doxycycline, and cultured for an additional 12 h at 30 C. The cultures were back-diluted to an OD 600 of 0.2 in 3 ml of SC-Ura/glucose without doxycycline and grown to mid-log phase. For visualization of vacuolar membrane, cells were stained with FM4-64 (Molecular Probes, Carlsbad, CA), as described previously. 26) Fluorescence in the non-fixed cells was observed using an Olympus BX51 microscope. Photographs were taken with an Olympus DP70 digital microscope camera. Images were processed with Adobe Photoshop CS2 software. 27) and we initially considered using this promoter in our system. However, because it was difficult to assess endosomal functions by invertase overlay assay on a galactose-containing plate, as described below (Fig. 2D) , we chose one of the alternative inducible gene expression systems as our screening system. Tetracycline-responsible (Tet-Off) promoter systems, which incorporate the artificial transcriptional element tTA transactivator (the VP16 activator domain of the herpes simplex virus fused to the tetracycline-inducible repressor, tetR, from the Tn10-encoded tetracycline-resistance operon), is useful in controlling gene expression in yeast. 28, 29) The expression of the advanced version of the mammalian TetOff Ò system (Clontech) can be more tightly controlled than that of the original system. 30) We adapted the advanced version of the mammalian Tet-Off Ò system for yeast and also combined this system with GatewayÔ cloning technology (Invitrogen) to make possible highthroughput gene cloning, and then constructed the GatewayÔ-compatible Tet-Off inducible expression vectors pMT735 (CEN URA3 P Tet-Off -attR1-Cm r -ccdBattR2-LAPG) and pMT830 (2" URA3 P Tet-Off -attR1-Cm r -ccdB-attR2-LAPG) (Fig. 1A, Table 2 ), as described in ''Materials and Methods.'' The LAPG-tag, which consists of a hexahistidine-tag and a GFP-tag with the tobacco etch virus (TEV) protease cleavage site between them, 23) was introduced downstream of the 3 0 -end of GatewayÔ cassette in these vectors, making possible the C-terminus tagging with LAPG by LR cloning. This tag makes possible functional analysis of genes of interest, such as localization analysis in yeast and proteomics analysis by tandem-affinity purification in yeast. 23) Another important point in our system is that because these plasmids simultaneously carry both a transactivator protein, tTA2
Results and Discussion
S , under the control of ADH1 promoter, and a Tet-Off promoter, TRE mod -CYC1 TATA, expression of a specific gene cloned into either plasmid is not required to transform it into specific strains expressing tTA2 from chromosome or other plasmid.
To validate this expression system, we determined the antibiotic-dependence and the kinetics of gene expression under the control of the Tet-Off promoter (Fig. 1B  and C respectively) . The Tet-Off promoter-driven GFP expression plasmids pMT921 (CEN P Tet-Off -GFP) and pMT922 (2" P Tet-Off -GFP) were constructed by removing of the GatewayÔ cassette from pMT735 and pMT830 respectively by inverse PCR (Table 2 ). Yeast AAAAAGCAGGCTTCACCATGCAAATACAGA-GCTTCTA SigD R1 AGAAAGCTGGGTAAGATGTGATTAATGAAGAA attB1 adaptor GGGGACAAGTTTGTACAAAAAAGCAGGCT attB2 adaptor GGGGACCACTTTGTACAAGAAAGCTGGGT cells carrying pMT921 or pMT922 growing under noninduction conditions with 20 mg/ml of tetracycline analogue doxycycline were washed and suspended in the same medium at different concentrations of doxycycline. Samples were harvested after 12 h of incubation at 30 C, and we subsequently determined GFP expression by immunoblot analysis. As shown in Fig. 1B , GFP expression in a dose-dependent manner was observed in cells carrying pMT921 or pMT922. GFP expression from a centromeric expression vector was repressed at >0:1 mg/ml of doxycycline, whereas that from a 2"-based expression vector was repressed at >5 mg/ml. These results indicate that gene expression levels can be titrated efficiently with the concentration of doxycycline in the medium and the copy number of the plasmid vector.
Next we analyzed the induction kinetics of the TetOff promoter vectors. Yeast cells carrying pMT921 or pMT922 growing under non-induction conditions with 20 mg/ml of doxycycline were washed and suspended in the same medium without doxycycline. Samples were taken at intervals to determine GFP expression. As shown in Fig. 1C , depletion of doxycycline led to rapid induction of GFP. Induction of GFP expression from a centromeric expression vector began at 9 h, whereas that from a 2"-based expression vector began at 3 h. These results indicate that gene expression due to these plasmid vectors can be tightly controlled by the concentration of doxycycline in the medium, allowing functional analysis of the proteins conferring a toxic phenotype on the yeast, such as pathogen effectors.
Generation of a yeast strain expressing a reporter to monitor endosomal function
Several intracellular pathogens, including Legionella pneumophilla and Salmonella typhimurium, escape from phagosomal degradation in host cells by translocating effectors that inhibit phagosomal maturation and modulate the host-vesicle trafficking pathway. 31) It has been found that the CPY-Inv reporter system is a powerful tool to identify the pathogen effectors that alter eukaryotic vesicle trafficking pathways. 15) Because the phenotypical differences caused by genetic differences in strains is one of the important issues in the yeast system, we generated a CPY-Inv reporter system in a yeast stain isogenic to yeast deletion collection (Research Genetics, Inc., Huntsville, AL). The PRC1-SUC2 fusion gene, encoding the CPY-Inv reporter, was integrated into the standard yeast haploid strain BY4742, as described in ''Materials and Methods'' (Fig. 2A) . The PRC1-SUC2 fusion gene was integrated into the chromosomal SUC2 allele, and this was confirmed by PCR (data not shown). To confirm further the expression of the CPY-Inv fusion protein, we examined the effect of expression of the Vps4 E233Q protein in a strain harboring the PRC1-SUC2 fusion gene. It has been found that the expression of Vps4 E233Q perturbs normal endosomal function and causes secretion of the CPY-Inv fusion protein to the cell surface (Fig. 2B) . 15, 32) Expression of the GFP-tagged Vps4
E233Q
protein under the control of both Tet-Off-and GAL1-promoter caused the formation of a brown precipitate, which indicated secretion of the CPY-Inv fusion protein to the cell surface, whereas the expression of GFP alone did not cause precipitate formation (Fig. 2C) . Notably, an invertase overlay assay using a plate containing galactose had higher background than that using a plate containing fructose (Fig. 2C) . This made it difficult to measure low invertase activity by Inv overlay assay. It was also found that strains expressing the Vps4 C for 12 h. Cell lysates were prepared and analyzed by SDS-PAGE and immunoblot. C, Kinetics of induction of GFP under the control of a Tet-Off promoter. Yeast cells harboring pMT921 or pMT922 plasmid growing exponentially in the presence of doxycycline (20 mg/ml) were deprived of doxycycline (time 0). Cell lysates were prepared at the indicated time points after doxycycline-deprivation and analyzed by SDS-PAGE and immunoblot. Glucose 6-phosphate dehydrogenase (G6PDH) was used as a loading control.
Consequently, secretion of the CPY-Inv fusion protein was slightly suppressed in these strains (Fig. 2C) . Induction-dependent expression of the Vps4 E233Q -GFP protein was confirmed by both immunoblot analysis (Fig. 2D ) and fluorescent microscopic analysis using the native fluoresce of GFP (Fig. 2E) . Vps4
E233Q -GFP was localized adjacent to the vacuole as visualized by FM4-64, where the organelle corresponding to class E compartments (Fig. 2E arrows) is. 32, 33) In sum, we generated the yeast strain expressing the CPY-Inv fusion 
panel). Expression of Vps4
E233Q perturbs endosomal function and the CPY-Inv fusion protein is secreted to the cell surface, which shows the Inv þ phenotype (right panel). C, Centromere (CEN) or multi-copy (2") plasmids carrying P Tet-Off -or P GAL1 -GFP or VPS4
E233Q -GFP were transformed to MTY483, a yeast diploid strain expressing the CPY-Inv fusion protein. Transformants carrying Tet-Off promoter plasmids were spotted on SC-Ura/fructose with and without 20 mg/ml doxycycline (ÀDox and þDox). Transformants carrying GAL1 promoter plasmids were spotted on SC-Ura/fructose or SC-Ura/galactose. Each transformant was grown for 2 d at 30 C, and Inv-overlay assay was performed as described in ''Materials and Methods.'' Secretion of the CPY-Inv fusion protein was detected by formation of a brown precipitate. D, Immunoblot analysis of Vps4 E233Q -GFP proteins expressed under the control of the Tet-Off promoter (left panel) or the GAL1 promoter (right panel). Protein expression was examined at 12 h after being shifted to the conditions indicated. E, Fluorescent microscopic analysis of Vps4 E233Q -GFP expression. The cells were stained with FM4-64 to visualize the vacuole membrane. Arrows indicate the predicted class E compartments.
protein to monitor endosomal functions, allowing identification of the pathogen effectors affecting the host vesicular trafficking pathway.
Optimization of pathogen-effector screening in yeast Next we evaluated this system and optimized the screening conditions using the pathogen effectors previously to confer a growth inhibitory phenotype on yeast. [9] [10] [11] Yersinia enterocolitica effectors (YopE, Rho-GAP; YopM, a leucine-rich repeat containing protein, unknown function; YpkA, protein kinase and RhoGDI) and Salmonella typhimurium effectors (SopE2, Rho-GEF; SptP, RhoGAP; SigD/SopB, Phosphoinositide phosphatase) were cloned into yeast-inducible expression plasmids, pMT751 and pMT830. Yeast cells carrying GFP-tagged pathogen effector expression plasmids were spotted in 10-fold serial dilution onto the induction (ÀDox for the Tet-Off promoter vectors and galactose for the GAL1 promoter vectors) or noninduction (þDox for the Tet-Off promoter vectors and fructose for the GAL1 promoter vectors) plates. Expression of YopE, SopE2, and SigD under the control of Tet-Off promoter conferred a severe inhibitory growth phenotype on a SC-Ura/fructose plate (Fig. 3A, upper A B Fig. 3 . Optimization of Screening Condition Using Known Pathogen Effectors.
A, Yersinia enterocolitica effector proteins (YopE, YopM, YpkA) and Salmonella typhimurium effector proteins (SopE2, SptP, SigD) were expressed in yeast cells under the control of the Tet-Off promoter or the GAL1 promoter. Yeast strains carrying Tet-Off promoter plasmids were cultured in SC-Ura/glucose with 20 mg/ml of doxycycline, and the exponential growth-phase cells were washed with the same medium without doxycycline and spotted in 10-fold serial dilution on SC-Ura/fructose with and without doxycycline. Yeast strains carrying GAL1 promoter plasmids were cultured in SC-Ura/glucose, and the exponential growth-phase cells were spotted on SC-Ura/fructose or galactose. The cells were grown at 30 C for 2 d for SC-Ura/fructose and 3 d for SC-Ura/galactose. B, Yeast cells expressing GFP alone, the full-length or transmembrane domain-deleted (ÁTM) version of Cpj0285, a Chlamydophila penumoniae effector candidate, or SigD were spotted in 10-fold serial dilution onto SC-Ura/fructose with and without doxycycline or SC-Ura/galactose without doxycyline and grown at 30 C for 2-3 d.
left panels). Expression of YpkA and SptP under the control of the Tet-Off promoter conferred a moderate growth inhibitory phenotype, whereas YopM expression conferred only a slight growth inhibitory phenotype on a SC-Ura/fructose plate, as compared to the cells expressing GFP alone (Fig. 3A, upper left panels) . The growth inhibitory phenotype by the expression of pathogen effectors from the GAL1 promoter was much more severe than that from the Tet-Off promoter (Fig. 3A, upper right panel) . A somewhat more severe growth inhibition phenotype due to pathogen effectors expressed under the control of the Tet-Off promoter was observed when cells were grown on a SC-Ura/galactose plate (Fig. 3A , lower panels) as compared to a SC-Ura/ fructose plate (Fig. 3A, upper left panels) . This additive growth inhibitory effect on a SC-Ura/galactose plate was much more clearly seen in the expression of Chlamydophila pneumoniae-effector candidates identified using the system developed in this study (Fig. 3B , our unpublished results). Although it is difficult to explain how a change in carbon source in yeast cells enhances the toxic effect of pathogen effectors, this additive growth inhibitory effect might improve efficiency in identifying the pathogen effectors exerting moderate toxicity on yeast.
In sum, we evaluated a system and optimize the conditions for pathogen effectors. We are currently trying to identify effector candidates in an obligate intracellular pathogen, Chlamydophila pneumoniae, and have started screening an array library consisting of 456 C. pneumoniae genes of unknown function using our system. The details of this screening along with characterizations of effector candidates identified using our system will be described elsewhere.
In conclusion, we developed a novel functional highthroughput screening system for pathogen effectors in yeast, one that consists of the GatewayÔ-compatible Tet-off inducible promoter vector and a yeast strain making possible identification of the pathogen effectors affecting the host vesicle trafficking pathways. This yeast system should be useful in functional genomewide screening of pathogen effectors using genome information on pathogenic bacteria.
